First Republic Investment Management, Inc. Atossa Therapeutics, Inc. Transaction History

First Republic Investment Management, Inc.

$34.7 Billion
Q3 2023

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	SELL	$0.85 - $1.28 $21,391 - $32,213	-25,167 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.11 - $1.74 $12,395 - $19,430	11,167 Added 79.76%	25,167 $31,000
Q4 2021 Feb 09, 2022	BUY	$1.6 - $3.27 $4,800 - $9,810	3,000 Added 27.27%	14,000 $22,000
Q3 2021 Nov 12, 2021	BUY	$2.89 - $6.4 $31,790 - $70,400	11,000 New	11,000 $36,000

Others Institutions Holding ATOS

# of Institutions

Shares Held

19.3M

Call Options Held

95K

Put Options Held

82.4K

Vanguard Group Inc Valley Forge, PA

5.75M
Shares

$6.67 Million
0.0% of portfolio
Black Rock Inc. New York, NY

2.75M
Shares

$3.19 Million
0.0% of portfolio
Laurion Capital Management LP New York, NY

2.23M
Shares

$2.58 Million
0.04% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

1.39M
Shares

$1.61 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

1.21M
Shares

$1.41 Million
0.0% of portfolio

View Full List

About ATOSSA THERAPEUTICS, INC.

Ticker ATOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,624,000
Market Cap $147M
Description
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing A...

More about ATOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Republic Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Republic Investment Management, Inc. with notifications on news.

Account